Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhibanqing Capsule in Hyperlipidemia (Phlegm-Blood Stasis Pattern)
CTR20140313Phase 3Active
- Sponsor
- Beijing Kaijin Technology
- Start
- May 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Zhibanqing in hyperlipidemia, sponsored by Beijing Kaijin Technology. Started May 2014; status: active.
02
Drugs
Zhibanqing
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on CTR20140313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140313.